Float Short %

2.87

Margin Of Safety %

Put/Call OI Ratio

0.92

EPS Next Q Diff

0.2

EPS Last/This Y

0.59

EPS This/Next Y

0.51

Price

76.23

Target Price

103.62

Analyst Recom

1.5

Performance Q

-8

Relative Volume

0.79

Beta

1.5

Ticker: DXCM

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	DXCM	80.98	0.93	1.42	149926
2025-08-18	DXCM	80.83	0.85	0.47	129233
2025-08-19	DXCM	80.91	0.85	0.23	129343
2025-08-20	DXCM	81.67	0.84	4.66	129742
2025-08-21	DXCM	80.64	0.89	2.15	132978
2025-08-22	DXCM	82.17	0.90	0.84	134723
2025-08-25	DXCM	75.91	0.91	0.68	132552
2025-08-26	DXCM	76.2	0.93	1.57	137101
2025-08-27	DXCM	76.37	0.94	0.67	139590
2025-08-28	DXCM	75.07	0.92	1.82	148729
2025-08-29	DXCM	75.32	0.94	1.48	156035
2025-09-02	DXCM	74.29	0.95	0.35	153528
2025-09-03	DXCM	78.92	0.94	0.39	155207
2025-09-04	DXCM	80.77	0.93	0.25	157496
2025-09-05	DXCM	80.53	0.92	0.82	159905
2025-09-08	DXCM	78.02	0.97	0.77	150760
2025-09-09	DXCM	78.39	0.97	1.68	152401
2025-09-10	DXCM	75.98	0.97	0.24	152732
2025-09-11	DXCM	76	0.93	0.95	157324
2025-09-12	DXCM	76.24	0.92	0.74	158331
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	DXCM	80.97	25.7	-0.1	2.05
2025-08-18	DXCM	80.81	25.7	-11.6	2.05
2025-08-19	DXCM	80.90	25.7	-9.4	2.05
2025-08-20	DXCM	81.67	25.7	-2.6	2.05
2025-08-21	DXCM	80.62	25.7	-20.5	2.05
2025-08-22	DXCM	82.26	25.7	6.2	2.05
2025-08-25	DXCM	75.94	25.7	-71.8	2.05
2025-08-26	DXCM	76.12	25.7	-8.5	2.05
2025-08-27	DXCM	76.37	25.7	-7.6	2.05
2025-08-28	DXCM	75.07	25.7	-24.0	2.05
2025-08-29	DXCM	75.31	25.7	-7.8	2.05
2025-09-02	DXCM	74.29	25.7	-21.4	2.05
2025-09-03	DXCM	78.91	25.7	267.3	2.05
2025-09-04	DXCM	80.78	25.7	228.0	2.05
2025-09-05	DXCM	80.51	25.7	200.8	2.05
2025-09-08	DXCM	78.00	25.7	172.3	2.05
2025-09-09	DXCM	78.38	25.7	209.0	2.05
2025-09-10	DXCM	75.99	25.7	172.7	2.05
2025-09-11	DXCM	76.00	25.8	203.7	2.05
2025-09-12	DXCM	76.23	25.8	207.1	2.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	DXCM	-2.29	1.61	2.19
2025-08-18	DXCM	-2.29	1.72	2.19
2025-08-19	DXCM	-2.28	1.72	2.19
2025-08-20	DXCM	-2.28	1.72	2.19
2025-08-21	DXCM	-2.28	1.72	2.19
2025-08-22	DXCM	-2.28	1.72	2.19
2025-08-25	DXCM	-2.28	0.39	2.19
2025-08-26	DXCM	-2.28	0.39	2.19
2025-08-27	DXCM	-2.28	0.39	2.56
2025-08-28	DXCM	-2.28	0.39	2.56
2025-08-29	DXCM	-2.28	0.39	2.56
2025-09-02	DXCM	-2.28	0.44	2.56
2025-09-03	DXCM	-2.28	0.44	2.56
2025-09-04	DXCM	-2.36	0.44	2.56
2025-09-05	DXCM	-2.36	0.44	2.56
2025-09-08	DXCM	-2.39	0.40	2.56
2025-09-09	DXCM	-2.37	0.40	2.56
2025-09-10	DXCM	-2.37	0.40	2.56
2025-09-11	DXCM	-2.37	0.40	2.87
2025-09-12	DXCM	-2.25	0.40	2.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.48

Avg. EPS Est. Current Quarter

0.57

Avg. EPS Est. Next Quarter

0.68

Insider Transactions

-2.25

Institutional Transactions

0.4

Beta

1.5

Average Sales Estimate Current Quarter

1177

Average Sales Estimate Next Quarter

1252

Fair Value

82.87

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.8

Max Drawdown 5-Year %

-63.3

Target Price

103.62

P/E

53.36

Forward P/E

29.44

PEG

2.17

P/S

6.95

P/B

11.62

P/Free Cash Flow

52.37

EPS

1.43

Average EPS Est. Cur. Y

2.05

EPS Next Y. (Est.)

2.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.29

Relative Volume

0.79

Return on Equity vs Sector %

-2.7

Return on Equity vs Industry %

3.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

207.1

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 10200

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y